Market News & Trends
Bio-Path Holdings Announces Collaboration With Thomas Jefferson University
Bio-Path Holdings, Inc. recently announced it has entered into a sponsored research agreement with Thomas Jefferson University to investigate DNAbilize antisense DNA technology for the…
XBiotech Signs Exclusive Licensing Agreement With Megapharm
XBiotech Inc., developer of next-generation True Human antibody therapies, recently announced that it has entered into an exclusive licensing agreement with Megapharm Ltd., to commercialize…
MilliporeSigma to Develop Next-Generation Purification Processes
MilliporeSigma has entered a research agreement with the International Vaccine Institute (IVI) of Seoul, South Korea to help develop more robust, scalable vaccine manufacturing processes.…
Kitov's Lead Drug Achieves Manufacturing Milestone Ahead of Planned NDA Filing With US FDA
Kitov Pharmaceuticals, an innovative biopharmaceutical company focused on late-stage drug development, recently announced that Dexcel Pharma, Kitov's manufacturing partner, has successfully completed an initial stability…
Evonik Acquires Transferra Nanosciences Inc.
Evonik and Transferra Nanosciences, Inc., formerly known as Northern Lipids Inc., recently announced they have signed an asset purchase agreement on June 21, 2016, to…
Pluristem Reports Data Showing PLX-PAD Cells Effective in Treating Duchenne Muscular Dystrophy
Pluristem Therapeutics Inc. recently reported positive data from preclinical studies of its PLX-PAD cells in the treatment of Duchenne muscular dystrophy. The studies were conducted…
ERT Develops Industry’s First Integration of Continuous Glucose Monitoring Data & eCOA
ERT, a leading provider of high-quality patient data collection solutions for use in clinical drug development, recently announced a data license agreement with Dexcom to…
Cobra Biologics & Alligator Bioscience Extend Drug Development Partnership
Cobra Biologics has recently been contracted to develop a second cell line for Alligator Bioscience AB. Alligator has requested further support from the team at…
Caladrius Subsidiary, PCT, to Manufacture Phase III Cell Therapy Product for Kiadis Pharma
Caladrius Biosciences, Inc. recently announced that PCT has expanded its relationship with Kiadis Pharma by entering into an agreement for the manufacturing of cell therapy…
Adaptimmune Announces Commercial Development & Supply Agreement
Adaptimmune Therapeutics plc recently announced it has entered into a commercial development and supply agreement with Thermo Fisher Scientific. The new 10-year agreement augments Adaptimmune’s…
Thermo Fisher Scientific & NIBRT Announce Scientific Collaboration
Thermo Fisher Scientific and the National Institute for Bioprocessing Research and Training (NIBRT) recently announced a scientific collaboration focused on the development of analytical solutions…
Co-Processed Excipients Benefit Market, Offer Opportunity
The excipients market is pharmaceutical manufacturing dependent, and the demand for excipients is constantly changing according to the production needs of manufacturers’ business strategies, marketing…
Hearty CAGRs for Global Cardiac Biomarker Market
The global cardiac biomarker market should see excellent growth rates among major regions due to the growing prevalence and incidence rates of cardiac diseases. BCC…
Co-Processed Excipients Benefit Market, Offer Opportunity
The excipients market is pharmaceutical manufacturing dependent, and the demand for excipients is constantly changing according to the production needs of manufacturers’ business strategies, marketing…
Hearty CAGRs for Global Cardiac Biomarker Market
The global cardiac biomarker market should see excellent growth rates among major regions due to the growing prevalence and incidence rates of cardiac diseases. BCC…
Sekisui XenoTech Introduces New Research BioBank
Sekisui XenoTech Introduces New Research BioBank As part of Sekisui XenoTech’s commitment to furthering knowledge of hepatic diseases, the company has begun providing disease-diagnosed tissue…
Sagent Pharmaceuticals Acquires Product Portfolio
Sagent Pharmaceuticals, Inc. recently announced it has entered into a definitive agreement with Teva Pharmaceutical Industries Ltd. (Teva) and Actavis LLC to acquire a portfolio…
Crown Bioscience Announces Strengthening of Global Immuno-Oncology Platform
Crown Bioscience recently announced the strengthening of its global Immuno-Oncology Platform at all its key facilities in Europe, US, and Asia to support client’s needs…
Argos Therapeutics Enters Strategic Research Agreement With Adaptive Biotechnologies
Argos Therapeutics, Inc. recently announced that it is partnering with Adaptive Biotechnologies Corporation, based in Seattle, WA, to study precise response patterns to Argos’ investigational…
Aegerion Pharmaceuticals & QLT Agree to Strategic Merger
Aegerion Pharmaceuticals, Inc. and QLT Inc. recently announced they have entered into a definitive merger agreement under which Aegerion will be merged with a wholly…
